DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C1535939 | Pneumocystis jiroveci pneumonia | CLEC6A | 93978 | C-type lectin domain containing 6A | Q6EIG7 |
C0027051 | Myocardial Infarction | CLEC6A | 93978 | C-type lectin domain containing 6A | Q6EIG7 |
C0027651 | Neoplasms | RAET1G | 353091 | retinoic acid early transcript 1G | Q6H3X3 |
C0004096 | Asthma | GALNT17 | 64409 | polypeptide N-acetylgalactosaminyltransferase 17 | Q6IS24 |
C1510586 | Autism Spectrum Disorders | GALNT17 | 64409 | polypeptide N-acetylgalactosaminyltransferase 17 | Q6IS24 |
C1306459 | Primary malignant neoplasm | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C1140680 | Malignant neoplasm of ovary | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0007102 | Malignant tumor of colon | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0699790 | Colon Carcinoma | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0006826 | Malignant Neoplasms | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C1837461 | SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0009402 | Colorectal Carcinoma | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0238463 | Papillary thyroid carcinoma | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0029408 | Degenerative polyarthritis | B4GALNT3 | 283358 | beta-1,4-N-acetyl-galactosaminyltransferase 3 | Q6L9W6 |
C0036572 | Seizures | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0013421 | Dystonia | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0040034 | Thrombocytopenia | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0015934 | Fetal Growth Retardation | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0242422 | Parkinsonian Disorders | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0149931 | Migraine Disorders | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0233794 | Memory impairment | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0008489 | Chorea | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0524851 | Neurodegenerative Disorders | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C0010038 | Corneal Opacity | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
C1531647 | Cerebral ventriculomegaly | MYORG | 57462 | myogenesis regulating glycosidase (putative) | Q6NSJ0 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024